🇺🇸 OGN — Organon & Co.

Salud Mantener
← Volver

Precio actual

13,85 USD

Máx. histórico

39,36

1707 días

Caída desde máximo

-64,81%

Rango 52 semanas

5,69 – 13,85

Variación hoy

+0,22%

Cierre anterior

13,82

Rango de hoy

13,83 – 13,85

Volumen hoy

3.657.869

Peor caída histórica

-82,69%

02/03/2022 → 30/03/2026

Aún sin recuperar

Volatilidad anualizada ⓘ

46,97%

Información
Nombre completo
Organon & Co.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
10.000
PER ⓘ
17,76 (puede no estar actualizado)
Dividend yield
0,58% (puede no estar actualizado)
Precio objetivo analistas
10,33 USD (puede no estar actualizado)
Primera cotización
14/05/2021
Precio actualizado
hace 20 horas
Sobre la empresa

Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon to prevent pregnancy; Follistim AQ, which is used to promote development of ovarian follicles; Elonva, a follicle stimulant; Ganirelix acetate injection, an injectable antagonist; Jada for abnormal postpartum uterine bleeding and hemorrhage; and Xaciato for bacterial vaginosis. Its biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; oncology products, including Ontruzant and Aybintio; Bildyos and Bilprevda, a recombinant anti-RANKL human monoclonal antibodies; and Poherdy, a neu receptor antagonist. The company also offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Atozet, Rosuzet, and Zocor brands; Cozaar and Hyzaar for hypertension; respiratory products to control and prevent asthma symptoms under the Singulair, Dulera, Zenhale, and Asmanex brands, as well as seasonal allergic rhinitis under the Nasonex, Clarinex, and Aerius brands. In addition, it provides dermatology products under the Vtama, Diprosone, and Elocon brand; bone health products under the Fosamax brand; and non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brands, as well as Proscar for symptomatic benign prostatic hyperplasia; and Propecia for male pattern hair loss. The company serves drug wholesalers and retailers, hospitals, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was founded in 1923 and is headquartered in Jersey City, New Jersey.

Dividendos repartidos Total últimos 12 meses: 0,0800 USD · Yield: 0,58%
Fecha de pago Importe por participación
14/08/2026 0,0200 USD
11/05/2026 0,0200 USD
23/02/2026 0,0200 USD
20/11/2025 0,0200 USD
15/08/2025 0,0200 USD
12/05/2025 0,0200 USD
24/02/2025 0,2800 USD
12/11/2024 0,2800 USD
16/08/2024 0,2800 USD
10/05/2024 0,2800 USD
23/02/2024 0,2800 USD
10/11/2023 0,2800 USD
17/08/2023 0,2800 USD
12/05/2023 0,2800 USD
24/02/2023 0,2800 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/05/2026 13,33 13,35 13,30 13,34 +0,23% 0,38% 5.805.600
12/05/2026 13,34 13,34 13,28 13,31 -0,15% 0,45% 4.864.400
11/05/2026 13,35 13,38 13,31 13,33 -0,15% 0,52% 4.928.200
08/05/2026 13,36 13,37 13,28 13,35 +0,23% 0,64% 6.777.300
07/05/2026 13,37 13,43 13,31 13,32 -0,67% 0,90% 8.092.600
06/05/2026 13,34 13,44 13,33 13,41 +0,45% 0,82% 8.263.600
05/05/2026 13,29 13,35 13,27 13,35 +0,68% 0,64% 7.240.000
04/05/2026 13,29 13,30 13,26 13,26 -0,23% 0,30% 6.412.100
01/05/2026 13,31 13,32 13,25 13,29 +0,30% 0,53% 9.978.200
30/04/2026 13,32 13,39 13,25 13,25 -0,67% 1,05% 14.909.200
29/04/2026 13,34 13,36 13,30 13,34 +0,15% 0,45% 17.214.600
28/04/2026 13,19 13,38 13,18 13,32 +1,22% 1,49% 36.739.800
27/04/2026 13,22 13,24 13,15 13,16 +16,87% 0,68% 133.824.400
24/04/2026 10,75 11,58 9,96 11,26 +30,93% 15,12% 31.875.900
23/04/2026 9,09 9,10 8,51 8,60 -5,91% 6,55% 4.266.000
22/04/2026 8,97 9,39 8,91 9,14 +3,39% 5,31% 6.603.900
21/04/2026 9,26 9,46 8,79 8,84 -4,54% 7,29% 5.599.700
20/04/2026 9,68 9,83 9,21 9,26 -5,12% 6,40% 7.249.800
17/04/2026 9,25 9,78 9,21 9,76 +4,61% 6,21% 7.003.200
16/04/2026 9,67 9,77 9,15 9,33 +1,30% 6,41% 10.268.300
15/04/2026 8,72 9,35 8,34 9,21 +5,86% 11,64% 9.638.400
14/04/2026 8,56 8,81 8,13 8,70 +1,87% 7,89% 6.954.900
13/04/2026 8,57 8,95 8,12 8,54 -3,28% 9,74% 14.085.200
10/04/2026 8,01 8,93 7,94 8,83 +27,79% 12,36% 39.484.100
09/04/2026 5,83 6,96 5,82 6,91 +17,92% 19,55% 10.019.100
08/04/2026 6,27 6,30 5,84 5,86 -4,25% 7,34% 4.985.300
07/04/2026 6,00 6,19 5,94 6,12 +1,16% 4,17% 3.022.200
06/04/2026 6,35 6,40 6,01 6,05 -4,87% 6,22% 2.960.100
02/04/2026 6,04 6,37 5,95 6,36 +3,58% 6,95% 3.396.700
01/04/2026 5,97 6,17 5,90 6,14 +2,50% 4,44% 4.465.600